dockets.justia.com/docket/florida/flndce/3:2019cv00214/102460

Jan 24, 2019 ... Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability case filed on January 24, 2019 in the Florida Northern District ...

law.justia.com/cases/federal/district-courts/california/candce/3:2017cv00244/306989/39

Jun 27, 2017 ... Ophelia Dubose v. Bristol-Myers Squibb Company et al, No. 3:2017cv00244 - Document 39 (N.D. Cal. 2017) case opinion from the Northern ...

www.cafc.uscourts.gov/sites/default/files/opinions-orders/17-1694.Opinion.2-7-2019.pdf

Feb 7, 2019 ... (all the claims) of United States Patent No. ... '239 Patent”) owned by Bristol- Myers Squibb Company ... Momenta Pharm., Inc. v. ... 311 et seq.

www.law360.com/cases/58e6506f2a2edd2f07000001

Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number 1:17-cv-00379, from  ...

www.ftc.gov/enforcement/cases-proceedings/0110046/bristol-myers-squibb-company-matter

May 25, 2004 ... Bristol-Myers Squibb Company (BMS) settled charges that it engaged in illegal business practices to delay the entry of three low price generic ...

www.alston.com/en/-/media/files/insights/publications/2018/05/class-action-roundup-spring-2018.pdf

May 25, 2018 ... Myers Squibb decision, with several opinions citing the case when dismissing .... Blackrock Allocation Target Shares: Series S Portfolio, et al. v. ... Medrano, et al. v . ... certification alleging that the company violated the Fair and .... recent Bristol- Myers Squibb decision was a qualifying “intervening change” in.